India’s supplements sector draws $70M as investors back scalable D2C brands

India’s nutraceuticals and supplements sector has attracted $70 million across 11 equity funding rounds in 2026 YTD, with investors targeting scalable, profitable wellness brands. OZiva, Cosmix, ZeroHarm Sciences and Earthful are among companies drawing PE and strategic FMCG interest.

— Source published Wed, 19 Aug, 2026, 20:18 IST · First seen Wed, 19 Aug, 2026, 20:20 IST · Source The Hindu BusinessLine

What happened

India nutraceuticals and supplements sector · India’s nutraceuticals and supplements sector attracted $70 million in 2026 YTD funding across 11 rounds, as

Key facts

  • $70 million equity funding in 2026 YTD
  • $59 million equity funding in 2020
  • 11 funding rounds in 2026 YTD
  • 30 funding rounds in 2020
  • Fireside Ventures has invested in around 14 health and wellness start-ups

Why this matters

Strategic FMCG buyers should monitor OZiva, Cosmix, ZeroHarm Sciences, and Earthful as potential partnership or acquisition targets that could accelerate wellness-category expansion.

What to watch

  • Follow-on rounds, acquisitions or minority strategic investments involving OZiva, Cosmix, ZeroHarm Sciences, Earthful or comparable brands.
  • Evidence that funded brands are expanding offline doors and quick-commerce availability faster than digital advertising spend.
  • Disclosures of repeat-purchase rates, EBITDA/profitability, contribution margins and customer-acquisition costs from leading brands.
  • FSSAI enforcement, tighter labeling rules or scrutiny of disease-treatment and efficacy claims.
  • New supplement launches, acquisitions or distribution partnerships by major Indian FMCG, consumer-health, pharmacy and nutrition companies.
  • Growth in protein, women’s wellness, gut health, metabolic health and healthy-aging segments relative to generic multivitamins.
  • Funded brands will prioritize omnichannel expansion into pharmacies, modern trade, gyms, clinics and quick-commerce platforms rather than relying solely on owned websites.
  • Leading D2C players will increase spending on formulation differentiation, testing, certifications, expert-led content and condition-specific product lines to defend pricing and trust.
  • PE firms and strategic FMCG buyers will screen for brands with high repeat rates, low customer-acquisition dependence, manufacturing control and regulatory-ready claim substantiation.
  • Marketplaces and quick-commerce operators may expand curated wellness assortments, subscription offers and health-goal discovery features as supplements become a higher-frequency basket.
  • Smaller supplement labels may pursue contract-manufacturing efficiencies, influencer partnerships, distributor alliances or strategic sales to remain competitive.

Also reported by